Aldose reductase inhibition suppresses oxidative stress-induced inflammatory disorders

Chemico-Biological Interactions

Volumn 191, Issue 1-3, 2011, Pages 330-338

  Srivastava, Satish K ^a   Yadav, Umesh C S ^a   Reddy, Aramati B M ^a   Saxena, Ashish ^a   Tammali, Ravinder ^a   Shoeb, Mohammad ^a   Ansari, Naseem H ^a   Bhatnagar, Aruni ^b   Petrash, Mark J ^c   Srivastava, Sanjay ^b   Ramana, Kota V ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF LOUISVILLE   (United States)

^c UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Aldose reductase; Asthma; Colon cancer; Inflammation; Oxidative stress; Uveitis

Indexed keywords

ALDEHYDE REDUCTASE; ALDEHYDE REDUCTASE INHIBITOR; ENZYME INHIBITOR; FIDARESTAT; SORBINIL; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ASTHMA; CELL PROLIFERATION; COLON CANCER; CONFERENCE PAPER; DETOXIFICATION; DIABETES MELLITUS; DRUG EFFICACY; DRUG SAFETY; ENZYME INHIBITION; HUMAN; INFLAMMATION; LIPID PEROXIDATION; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; PROTEIN FUNCTION; RESPIRATORY TRACT INFLAMMATION; SEPSIS; SMOOTH MUSCLE FIBER; UVEITIS; VASCULAR SMOOTH MUSCLE;

ALDEHYDE REDUCTASE; ANIMALS; ANTIOXIDANTS; ENZYME INHIBITORS; HUMANS; INFLAMMATION; OXIDATIVE STRESS;

ANIMALIA;

EID: 79957549510     PISSN: 00092797     EISSN: 18727786     Source Type: Journal    
DOI: 10.1016/j.cbi.2011.02.023     Document Type: Conference Paper

References (120)

1. S. Srivastava, A. Chandra, A. Bhatnagar, S.K. Srivastava, N.H. Ansari, Lipid peroxidation product, 4-hydroxynonenal and its conjugate with GSH are excellent substrates of bovine lens aldose reductase, Biochem. Biophys. Res. Commun. 217 (1995) 741-746.
2. I.G. Obrosova, S.S. Chung, P.F. Kador, Diabetic cataracts: mechanisms and management, Diabetes Metab. Res. Rev. 26 (2010) 172-180.
3. M. Lorenzi, The polyol pathway as a mechanism for diabetic retinopathy: attractive, elusive, and resilient, Exp. Diabetes Res. 2007 (2007) 61038.
4. P.J. Oates, Aldose reductase, still a compelling target for diabetic neuropathy, Curr. Drug Targets 9 (2008) 14-36. (Pubitemid 351201678)
5. M. Dunlop, Aldose reductase and the role of the polyol pathway in diabetic nephropathy, Kidney Int. Suppl. 77 (2000) S3-12.
6. S.S. Chung, S.K. Chung, Aldose reductase in diabetic microvascular complications, Curr. Drug Targets 6 (2005) 475-486. (Pubitemid 40921713)
7. Q. Li, Y.C. Hwang, R. Ananthakrishnan, P.J. Oates, D. Guberski, R. Ramasamy, Polyol pathway and modulation of ischemia-reperfusion injury in Type 2 diabetic BBZ rat hearts, Cardiovasc. Diabetol. 7 (2008) 33.
8. S.K. Srivastava, K.V. Ramana, A. Bhatnagar, Role of aldose reductase and oxidative damage in diabetes and the consequent potential for therapeutic options, Endocr. Rev. 26 (2005) 380-392.
9. A.Y. Lee, S.K. Chung, S.S. Chung, Demonstration that polyol accumulation is responsible for diabetic cataract by the use of transgenic mice expressing the aldose reductase gene in the lens, Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 2780-2784.
10. S. Suzen, E. Buyukbingol, Recent studies of aldose reductase enzyme inhibition for diabetic complications, Curr. Med. Chem. 10 (2003) 1329-1352. (Pubitemid 36896564)
11. S. Narayanan, Aldose reductase and its inhibition in the control of diabetic complications, Ann. Clin. Lab. Sci. 23 (1993) 148-158. (Pubitemid 23093793)
12. G.J. Zenon 3rd, C.V. Abobo, B.L. Carter, D.W. Ball, Potential use of aldose reductase inhibitors to prevent diabetic complications, Clin. Pharm. 9 (1990) 446-457.
13. A.Y. Lee, S.S. Chung, Contributions of polyol pathway to oxidative stress in diabetic cataract, FASEB J. 13 (1999) 23-30. (Pubitemid 29038271)
14. S.S. Chung, E.C. Ho, K.S. Lam, S.K. Chung, Contribution of polyol pathway to diabetes-induced oxidative stress, J. Am. Soc. Nephrol. 14 (2003) S233-S236. (Pubitemid 36903931)
15. N.H. Ansari, A. Bhatnagar, E. Fulep, P. Khanna, S.K. Srivastava, Trolox protects hyperglycemia-induced cataractogenesis in cultured rat lens, Res. Commun. Chem. Pathol. Pharmacol. 84 (1994) 93-104. (Pubitemid 24127656)
16. S.K. Srivastava, N.H. Ansari, Prevention of sugar-induced cataractogenesis in rats by butylated hydroxytoluene, Diabetes 37 (1988) 1505-1508.
17. M. Carini, G. Aldini, R.M. Facino, Mass spectrometry for detection of 4- hydroxy-trans-2-nonenal (HNE) adducts with peptides and proteins, Mass Spectrom. Rev. 23 (2004) 281-305.
18. J. Galle, K. Heermeier, C. Wanner, Atherogenic lipoproteins, oxidative stress, and cell death, Kidney Int. Suppl. 71 (1999) S62-65.
19. M.E. Rosenfeld, Inflammation, lipids, and free radicals: lessons learned from the atherogenic process, Semin. Reprod. Endocrinol. 16 (1998) 249-261.
20. W. Martinet, M.M. Kockx, Apoptosis in atherosclerosis: focus on oxidized lipids and inflammation, Curr. Opin. Lipidol. 12 (2001) 535-541. (Pubitemid 32980302)
21. M. Uemura, H. Manabe, N. Yoshida, N. Fujita, J. Ochiai, N. Matsumoto, T. Takagi, Y. Naito, T. Yoshikawa, Alpha-tocopherol prevents apoptosis of vascular endothelial cells via a mechanism exceeding that of mere antioxidation, Eur. J. Pharmacol. 456 (2002) 29-37.
22. S.A. Evensen, K.S. Galdal, E. Nilsen, LDL-induced cytotoxicity and its inhibition by anti-oxidant treatment in culturedhumanendothelial cells and fibroblasts, Atherosclerosis 49 (1983) 23-30. (Pubitemid 14227972)
23. E. Obrador, J. Navarro, J. Mompo, M. Asensi, J.A. Pellicer, J.M. Estrela, Regulation of tumour cell sensitivity to TNF-α-induced oxidative stress and cytotoxicity: role of glutathione, Biofactors 8 (1998) 23-26. (Pubitemid 28332780)
24. M. Kanitkar, K. Gokhale, S. Galande, R.R. Bhonde, Novel role of curcumin in the prevention of cytokine-induced islet death in vitro and diabetogenesis in vivo, Br. J. Pharmacol. 155 (2008) 702-713.
25. C. Premanand, M. Rema, M.Z. Sameer, M. Sujatha, M. Balasubramanyam, Effect of curcumin on proliferation of human retinal endothelial cells under in vitro conditions, Invest. Ophthalmol. Vis. Sci. 47 (2006) 2179-2184. (Pubitemid 46768303)
26. B.I. Babu, G. Malleo, T. Genovese, E. Mazzon, R. Di Paola, C. Crisafulli, R. Caminiti, A.K. Siriwardena, S. Cuzzocrea, Green tea polyphenols ameliorate pancreatic injury in cerulein-induced murine acute pancreatitis, Pancreas 38 (2009) 954-967.
27. B.L. Dixit, G.K. Balendiran, S.J. Watowich, S. Srivastava, K.V. Ramana, J.M. Petrash, A. Bhatnagar, S.K. Srivastava, Kinetic and structural characterization of the glutathione-binding site of aldose reductase, J. Biol. Chem. 275 (2000) 21587-21595.
28. K.V. Ramana, A. Bhatnagar, S. Srivastava, U.C. Yadav, S. Awasthi, Y.C. Awasthi, S.K. Srivastava, Mitogenic responses of vascular smooth muscle cells to lipid peroxidation-derived aldehyde 4-hydroxy-trans-2-nonenal (HNE): role of aldose reductase-catalyzed reduction of the HNE-glutathione conjugates in regulating cell growth, J. Biol. Chem. 281 (2006) 17652-17660.
29. K.V. Ramana, D. Chandra, S. Srivastava, A. Bhatnagar, S.K. Srivastava, Aldose reductase mediates the mitogenic signals of cytokines, Chem. Biol. Interact. 143-144 (2003) 587-596. (Pubitemid 36253605)
30. D. Chandra, K.V. Ramana, B. Friedrich, S. Srivastava, A. Bhatnagar, S.K. Srivastava, Role of aldose reductase in TNF-alpha-induced apoptosis of vascular endothelial cells, Chem. Biol. Interact. 143-144 (2003) 605-612. (Pubitemid 36253606)
31. A. Catalá, Lipid peroxidation of membrane phospholipids generates hydroxy-alkenals and oxidized phospholipids active in physiological and/or pathological conditions, Chem. Phys. Lipids 157 (2009) 1-11.
32. S. Srivastava, B.L. Dixit, J. Cai, S. Sharma, H.E. Hurst, A. Bhatnagar, S.K. Srivastava, Metabolism of lipid peroxidation product, 4-hydroxynonenal (HNE) in rat erythrocytes: role of aldose reductase, Free Radic. Biol. Med. 29 (2000) 642-651.
33. D.L. Vander Jagt, N.S. Kolb, T.J. Vander Jagt, J. Chino, F.J. Martinez, L.A. Hunsaker, R.E. Royer, Substrate specificity of human aldose reductase: identification of 4-hydroxynonenal as an endogenous substrate, Biochim. Biophys. Acta 1249 (1995) 117-126.
34. A. Bhatnagar, S.Q. Liu, N. Ueno, B. Chakrabarti, S.K. Srivastava, Human placental aldose reductase: role of Cys-298 in substrate and inhibitor binding, Biochim. Biophys. Acta 1205 (1994) 207-214.
35. K.V. Ramana, B.L. Dixit, S. Srivastava, A. Bhatnagar, G.K. Balendiran, S.J. Watowich, J.M. Petrash, S.K. Srivastava, Characterization of the glutathione binding site of aldose reductase, Chem. Biol. Interact. 130-132 (2001) 537-548. (Pubitemid 32295842)
36. R. Singh, M.A. White, K.V. Ramana, J.M. Petrash, S.J. Watowich, A. Bhatnagar, S.K. Srivastava, Structure of a glutathione conjugate bound to the active site of aldose reductase, Proteins 64 (2006) 101-110. (Pubitemid 43830989)
37. S. Srivastava, A. Chandra, L.F. Wang, W.E. Seifert Jr., B.B. DaGue, N.H. Ansari, S.K. Srivastava, A. Bhatnagar, Metabolism of the lipid peroxidation product, 4-hydroxy-trans-2-nonenal, in isolated perfused rat heart, J. Biol. Chem. 273 (1998) 10893-10900. (Pubitemid 28204926)
38. S. Srivastava, A. Chandra, N.H. Ansari, S.K. Srivastava, A. Bhatnagar, Identification of cardiac oxidoreductase(s) involved in the metabolism of the lipid peroxidation-derived aldehyde-4-hydroxynonenal, Biochem. J. 329 (1998) 469-475. (Pubitemid 28055167)
39. S.E. Spycher, S. Tabataba-Vakili, V.B. O'Donnell, L. Palomba, A. Azzi, Aldose reductase induction: a novel response to oxidative stress of smooth muscle cells, FASEB J. 11 (1997) 181-188. (Pubitemid 27097592)
40. D.K. Hsu, Y. Guo, K.A. Peifley, J.A. Winkles, Differential control of murine aldose reductase and fibroblast growth factor (FGF)-regulated-1 gene expression in NIH 3T3 cells by FGF-1 treatment and hyperosmotic stress, Biochem. J. 328 (1997) 593-598. (Pubitemid 27515605)
41. C. Jacquin-Becker, G. Labourdette, Regulation of aldose reductase expression in rat astrocytes in culture, Glia 20 (1997) 135-144. (Pubitemid 27253206)
42. J. Ruef, S.Q. Liu, C. Bode, M. Tocchi, S. Srivastava, M.S. Runge, A. Bhatnagar, Involvement of aldose reductase in vascular smooth muscle cell growth and lesion formation after arterial injury, Arterioscler. Thromb. Vasc. Biol. 20 (2000) 1745-1752. (Pubitemid 30470589)
43. M. Takahashi, J. Fujii, E. Miyoshi, A. Hoshi, N. Taniguchi, Elevation of aldose reductase gene expression in rat primary hepatoma and hepatoma cell lines: implication in detoxification of cytotoxic aldehydes, Int. J. Cancer 62 (1995) 749-754.
44. E. Zeindl-Eberhart, P.R. Jungblut, A. Otto, R. Kerler, H.M. Rabes, Further characterization of a rat hepatoma-derived aldose-reductase-like protein - organ distribution and modulation in vitro, Eur. J. Biochem. 247 (1997) 792-800.
45. U.C. Yadav, F. Ighani-Hosseinabad, F.J. van Kuijk, S.K. Srivastava, K.V. Ramana, Prevention of posterior capsular opacification through aldose reductase inhibition, Invest. Ophthalmol. Vis. Sci. 50 (2009) 752-759.
46. S. Shi, I. Bekhor, Abnormal expression of aldose reductase mRNA in fiber cells of cataractous rat lens. Analysis by in situ hybridization, Mol. Cell. Biochem. 131 (1994) 35-41. (Pubitemid 24139173)
47. S. Srivastava, D.J. Conklin, S.Q. Liu, N. Prakash, P.J. Boor, S.K. Srivastava, A. Bhatnagar, Identification of biochemical pathways for the metabolism of oxidized low-density lipoprotein derived aldehyde-4-hydroxy trans-2-nonenal in vascular smooth muscle cells, Atherosclerosis 158 (2001) 339-350. (Pubitemid 32913643)
48. H.L. Rittner, V. Hafner, P.A. Klimiuk, L.I. Szweda, J.J. Goronzy, C.M. Weyand, Aldose reductase functions as a detoxification system for lipid peroxidation products in vasculitis, J. Clin. Invest. 103 (1999) 1007-1013.
49. C. Godon, G. Lagniel, J. Lee, J.M. Buhler, S. Kieffer, M. Perrot, H. Boucherie, M.B. Toledano, J. Labarre, The H2O2 stimulon in Saccharomyces cerevisiae, J. Biol. Chem. 273 (1998) 22480-22489.
50. Y. Kasuya, M. Ito, J. Nakamura, Y. Hamada, M. Nakayama, S. Chaya, T. Komori, K. Naruse, E. Nakashima, K. Kato, N. Koh, N. Hotta, An aldose redutase inhibitor prevents the intimal thickening in coronary arteries of galactose-fed beagle dogs, Diabetologia 42 (1999) 1404-1409. (Pubitemid 30012310)
51. B. Halliwell, Mechanisms involved in the generation of free radicals, Pathol. Biol. (Paris) 44 (1996) 6-13. (Pubitemid 26088472)
52. H.J. Forman, M. Torres, Redox signaling in macrophages, Mol. Aspects Med. 22 (2001) 189-216.
53. E. Galkina, K. Ley, Immune and inflammatory mechanisms of atherosclerosis, Annu. Rev. Immunol. 27 (2009) 165-197.
54. P.L. Hordijk, Regulation of NADPH oxidases: the role of Rac proteins, Circ. Res. 98 (2006) 453-462.
55. C.H. Wu, C.F. Wu, H.W. Huang, Y.C. Jao, G.C. Yen, Naturally occurring flavonoids attenuate high glucose-induced expression of proinflammatory cytokines in human monocytic THP-1 cells, Mol. Nutr. Food Res. 53 (2009) 984-995.
56. J. El-Benna, P.M. Dang, M.A. Gougerot-Pocidalo, J.C. Marie, F. Braut-Boucher, p47phox, the phagocyte NADPH oxidase/NOX2 organizer: structure, phosphorylation and implication in diseases, Exp. Mol. Med. 41 (2009) 217-225.
57. N.M. Mustapha, M.T. Joanna, E.M. Kohner, R. Chibber, NADPH oxidase versus mitochondria-derived ROS in glucose-induced apoptosis of pericytes in early diabetic retinopathy, J. Ophthalmol. (2010), doi:10.1155/2010/746978 (Article ID: 746978).
58. C.E. Murdoch, M. Zhang, A.C. Cave, A.M. Shah, NADPH oxidase-dependent redox signalling in cardiac hypertrophy, remodelling and failure, Cardiovasc. Res. 71 (2006) 208-215.
59. T. Seno, N. Inoue, D. Gao, M. Okuda, Y. Sumi, K. Matsui, S. Yamada, K.I. Hirata, S. Kawashima, R. Tawa, S. Imajoh-Ohmi, H. Sakurai, M. Yokoyama, Involvement of NADH/NADPH oxidase in human platelet ROS production, Thromb. Res. 103 (2001) 399-409.
60. E. Ho, G. Chen, T.M. Bray, Supplementation of N-acetylcysteine inhibits NFkappaB activation and protects against alloxan-induced diabetes in CD-1 mice, FASEB J. 13 (1999) 1845-1854. (Pubitemid 29473348)
61. D. Gius, A. Botero, S. Shah, H.A. Curry, Intracellular oxidation/reduction status in the regulation of transcription factors NF-kappaB and AP-1, Toxicol. Lett. 106 (1999) 93-106.
62. M. Karin, E. Shaulian, AP-1: linking hydrogen peroxide and oxidative stress to the control of cell proliferation and death, IUBMB Life 52 (2001) 17-24. (Pubitemid 33769664)
63. M. Karin, The regulation of AP-1 activity by mitogen-activated protein kinases, J. Biol. Chem. 270 (1995) 16483-16486.
64. G. Poli, R.J. Schaur, 4-Hydroxynonenal in the pathomechanisms of oxidative stress, IUBMB Life 50 (2000) 315-321. (Pubitemid 32289090)
65. M. Parola, G. Bellomo, G. Robino, G. Barrera, M.U. Dianzani, 4-Hydroxynonenal as a biological signal: molecular basis and pathophysiological implications, Antioxid. Redox Signal. 1 (1999) 255-284.
66. C. Asselin, B. Bouchard, J.C. Tardif, C. Des Rosiers, Circulating 4- hydroxynonenal-protein thioether adducts assessed by gas chromatography-mass spectrometry are increased with disease progression and aging in spontaneously hypertensive rats, Free Radic. Biol. Med. 41 (2006) 97-105. (Pubitemid 43866456)
67. D.V. Nadkarni, L.M. Sayre, Structural definition of early lysine and histidine adduction chemistry of 4-hydroxynonenal, Chem. Res. Toxicol. 8 (1995) 284-291.
68. F. Cajone, M. Crescente, In vitro activation of heat shock transcription factor by 4-hydroxynonenal, Chem. Biol. Interact. 84 (1992) 97-112.
69. H. Esterbauer, Cytotoxicity and genotoxicity of lipid-oxidation products, Am. J. Clin. Nutr. 57 (Suppl. 5) (1993) 779S-785S.
70. E. Zamara, E. Novo, F. Marra, A. Gentilini, R.G. Romanelli, A. Caligiuri, G. Robino, E. Tamagno, M. Aragno, O. Danni, R. Autelli, S. Colombatto, M.U. Dianzani, M. Pinzani, M. Parola, 4-Hydroxynonenal as a selective pro-fibrogenic stimulus for activated human hepatic stellate cells, J. Hepatol. 40 (2004) 60-68. (Pubitemid 38067269)
71. J.Y. Lee, J.H. Je, D.H. Kim, S.W. Chung, Y. Zou, N.D. Kim, M. Ae Yoo, H. Suck Baik, B.P. Yu, H.Y. Chung, Induction of endothelial apoptosis by 4-hydroxyhexenal, Eur. J. Biochem. 271 (2004) 1339-1347.
72. S. Choudhary, W. Zhang, F. Zhou, G.A. Campbell, L.L. Chan, E.B. Thompson, N.H. Ansari, Cellular lipid peroxidation end-products induce apoptosis in human lens epithelial cells, Free Radic. Biol. Med. 32 (2002) 360-369. (Pubitemid 34159090)
73. P.M. Eckl, Genotoxicity of HNE, Mol. Aspects Med. 24 (2003) 161-165.
74. S. Spycher, S. Tabataba-Vakili, V.B. O'Donnell, L. Palomba, A. Azzi, 4-Hydroxy- 2,3-trans-nonenal induces transcription and expression of aldose reductase, Biochem. Biophys. Res. Commun. 226 (1996) 512-516.
75. H.J. Martin, E. Maser, Role of human aldo-keto-reductase AKR1B10 in the protection against toxic aldehydes, Chem. Biol. Interact. 178 (2009) 145-150.
76. K.V. Ramana, A.A. Fadl, R. Tammali, A.B. Reddy, A.K. Chopra, S.K. Srivastava, Aldose reductase mediates the lipopolysaccharide-induced release of inflammatory mediators in RAW264.7 murine macrophages, J. Biol. Chem. 281 (2006) 33019-33029.
77. H.J. Mackay, C.J. Twelves, Targeting the protein kinase C family: are we there yet? Nat. Rev. Cancer 7 (2007) 554-562. (Pubitemid 46985395)
78. M. Musashi, S. Ota, N. Shiroshita, The role of protein kinase C isoforms in cell proliferation and apoptosis, Int. J. Hematol. 72 (2000) 12-19.
79. U.M.Marinari, M. Nitti, M.A. Pronzato, C. Domenicotti, Role of PKC-dependent pathways in HNE-induced cell protein transport and secretion, Mol. Aspects Med. 24 (2003) 205-211.
80. K.V. Ramana, B. Friedrich, R. Tammali, M.B. West, A. Bhatnagar, S.K. Srivastava, Requirement of aldose reductase for the hyperglycemic activation of protein kinase C and formation of diacylglycerol in vascular smooth muscle cells, Diabetes 54 (2005) 818-829. (Pubitemid 40322087)
81. K.V. Ramana, D. Chandra, S. Srivastava, A. Bhatnagar, B.B. Aggarwal, S.K. Srivastava, Aldose reductase mediates mitogenic signaling in vascular smooth muscle cells, J. Biol. Chem. 277 (2002) 32063-32070.
82. R. Tammali, K.V. Ramana, S.K. Srivastava, Aldose reductase regulates TNF-alpha-induced PGE2 production in human colon cancer cells, Cancer Lett. 252 (2007) 299-306. (Pubitemid 46823949)
83. K.V. Ramana, A. Bhatnagar, S.K. Srivastava, Aldose reductase regulates TNF-alpha- induced cell signaling and apoptosis in vascular endothelial cells, FEBS Lett. 570 (2004) 189-194. (Pubitemid 38900980)
84. K.V. Ramana, B. Friedrich, A. Bhatnagar, S.K. Srivastava, Aldose reductase mediates cytotoxic signals of hyperglycemia and TNF-alpha in human lens epithelial cells, FASEB J. 17 (2003) 315-317.
85. G.L. King, T. Shiba, J. Oliver, T. Inoguchi, S.E. Bursell, Cellular and molecular abnormalities in the vascular endothelium of diabetes mellitus, Annu. Rev. Med. 45 (1994) 179-188. (Pubitemid 24158154)
86. M. Brownlee, Biochemistry and molecular cell biology of diabetic complications, Nature 414 (2001) 813-820. (Pubitemid 34000785)
87. P.R. Cammarata, H.Q. Chen, J. Yang, T. Yorio, Modulation of myo-[3H]inositol uptake by glucose and sorbitol in cultured bovine lens epithelial cells. II. Characterization of high- and low-affinity myo-inositol transport sites, Invest. Ophthalmol. Vis. Sci. 33 (1992) 3572-3580. (Pubitemid 23001373)
88. E.S. Kang, H.J. Kim, K.S. Paek, H.S. Jang, K.C. Chang, J.H. Lee, T. Nishinaka, C. Yabe-Nishimura, H.G. Seo, Phorbol ester up-regulates aldose reductase expression in A549 cells: a potential role for aldose reductase in cell cycle modulation, Cell. Mol. Life Sci. 62 (2005) 1146-1155. (Pubitemid 40872238)
89. T. Yamaoka, A. Oda, C. Bannai, M. Itakura, K. Yamashita, The effect of non-enzymatic glycation on recombinant human aldose reductase, Diabetes Res. Clin. Pract. 27 (1995) 165-169.
90. Q. Dan, R. Wong, S.K. Chung, S.S. Chung, K.S. Lam, Interaction between the polyol pathway and non-enzymatic glycation on aortic smooth muscle cell migration and monocyte adhesion, Life Sci. 76 (2004) 445-459. (Pubitemid 39458312)
91. Y. Hamada, N. Araki, N. Koh, J. Nakamura, S. Horiuchi, N. Hotta, Rapid formation of advanced glycation end products by intermediate metabolites of glycolytic pathway and polyol pathway, Biochem. Biophys. Res. Commun. 228 (1996) 539-543. (Pubitemid 26396108)
92. R.H. Nagaraj, M. Prabhakaram, B.J. Ortwerth, V.M. Monnier, Suppression of pentosidine formation in galactosemic rat lens by an inhibitor of aldose reductase, Diabetes 43 (1994) 580-586. (Pubitemid 24096300)
93. Y.C. Hwang, M. Kaneko, S. Bakr, H. Liao, Y. Lu, E.R. Lewis, S. Yan, S. Ii, M. Itakura, L. Rui, H. Skopicki, S. Homma, A.M. Schmidt, P.J. Oates, M. Szabolcs, R. Ramasamy, Central role for aldose reductase pathway in myocardial ischemic injury, FASEB J. 18 (2004) 1192-1199. (Pubitemid 39006881)
94. C.N. Sessler, W. Shepherd, New concepts in sepsis, Curr. Opin. Crit. Care 8 (2002) 465-472.
95. G.S. Martin, D.M. Mannino, S. Eaton, M. Moss, The epidemiology of sepsis in the United States from 1979 through 2000, N. Engl. J. Med. 348 (2003) 1546-1554.
96. A. Waage, P. Brandtzaeg, T. Espevik, A. Halstensen, Current understanding of the pathogenesis of Gram-negative shock, Infect. Dis. Clin. North Am. 5 (1991) 781-791.
97. A.B. Reddy, S.K. Srivastava, K.V. Ramana, Anti-inflammatory effect of aldose reductase inhibition in murine polymicrobial sepsis, Cytokine 48 (2009) 170-176.
98. K.V. Ramana, M.S. Willis, M.D. White, J.W. Horton, J.M. DiMaio, D. Srivastava, A. Bhatnagar, S.K. Srivastava, Endotoxin-induced cardiomyopathy and systemic inflammation in mice is prevented by aldose reductase inhibition, Circulation 114 (2006) 1838-1846. (Pubitemid 44673359)
99. S.S. Braman, The global burden of asthma, Chest 130 (Suppl. 1) (2006) 4S-12S.
100. R. Louis, L.C. Lau, A.O. Bron, A.C. Roldaan, M. Radermecker, R. Djukanović, The relationship between airways inflammation and asthma severity, Am. J. Respir. Crit. Care Med. 161 (2000) 9-16. (Pubitemid 30055896)
101. Q. Hamid, M. Tulic, Immunobiology of asthma, Annu. Rev. Physiol. 71 (2009) 489-507.
102. P. Fireman, Understanding asthma pathophysiology, Allergy Asthma Proc. 24 (2003) 79-83. (Pubitemid 37034191)
103. U.S. Björnsdottir, D.M. Cypcar, Asthma: an inflammatory mediator soup, Allergy 54 (1999) 55-61. (Pubitemid 29292494)
104. U.C. Yadav, K.V. Ramana, L. Aguilera-Aguirre, I. Boldogh, H.A. Boulares, S.K. Srivastava, Inhibition of aldose reductase prevents experimental allergic airway inflammation in mice, PLoS One 4 (2009) e6535.
105. U.C. Yadav, A.S. Naura, L. Aguilera-Aguirre, K.V. Ramana, I. Boldogh, S. Sur, H.A. Boulares, S.K. Srivastava, Aldose reductase inhibition suppresses the expression of Th2 cytokines and airway inflammation in ovalbumin-induced asthma in mice, J. Immunol. 183 (2009) 4723-4732.
106. U.C. Yadav, S.K. Srivastava, K.V. Ramana, Aldose reductase inhibition prevents endotoxin-induced uveitis in rats, Invest. Ophthalmol. Vis. Sci. 48 (2007) 4634-4642. (Pubitemid 351260981)
107. B.W. Stewart, P. Kleihues (Eds.), World Cancer Report, IARC Press, Lyon, 2003.
108. E.N. Alcantara, E.W. Speckmann, Diet, nutrition, and cancer, Am. J. Clin. Nutr. 29 (1976) 1035-1047.
109. E. Shacter, S.A. Weitzman, Chronic inflammation and cancer, Oncology 16 (2002) 217-226.
110. S. Kraus, N. Arber, Inflammation and colorectal cancer, Curr. Opin. Pharmacol. 9 (2009) 405-410.
111. R. Tammali, K.V. Ramana, S.S. Singhal, S. Awasthi, S.K. Srivastava, Aldose reductase regulates growth factor-induced cyclooxygenase-2 expression and prostaglandin E2 production in human colon cancer cells, Cancer Res. 66 (2006) 9705-9713. (Pubitemid 44623671)
112. S.A. Weaver, M.P. Russo, K.L. Wright, G. Kolios, C. Jobin, D.A. Robertson, S.G. Ward, Regulatory role of phosphatidylinositol 3-kinase on TNF-α-induced cyclooxygenase 2 expression in colonic epithelial cells, Gastroenterology 120 (2001) 1117-1127. (Pubitemid 32246666)
113. R. Atreya, M.F. Neurath, Involvement of IL-6 in the pathogenesis of inflammatory bowel disease and colon cancer, Clin. Rev. Allergy Immunol. 28 (2005) 187-196.
114. W. Liu, N. Reinmuth, O. Stoeltzing, A.A. Parikh, C. Tellez, S. Williams, Y.D. Jung, F. Fan, A. Takeda, M. Akagi, M. Bar-Eli, G.E. Gallick, L.M. Ellis, Cyclooxygenase- 2 is up-regulated by interleukin-1 beta in human colorectal cancer cells via multiple signaling pathways, Cancer Res. 63 (2003) 3632-3636. (Pubitemid 36793046)
115. Y.J. Surh, J.K. Kundu, H.K. Na, J.S. Lee, Redox-sensitive transcription factors as prime targets for chemoprevention with anti-inflammatory and antioxidative phytochemicals, J. Nutr. 135 (2005) 2993S-3001S.
116. K.V. Ramana, R. Tammali, S.K. Srivastava, Inhibition of aldose reductase prevents growth factor-induced G1-S phase transition through the AKT/phosphoinositide 3-kinase/E2F-1 pathway in human colon cancer cells, Mol. Cancer Ther. 9 (2010) 813-824.
117. R. Tammali, A.B. Reddy, K.V. Ramana, J.M. Petrash, S.K. Srivastava, Aldose reductase deficiency in mice prevents azoxymethane-induced colonic preneoplastic aberrant crypt foci formation, Carcinogenesis 30 (2009) 799-807.
118. M. Saraswat, T. Mrudula, P.U. Kumar, A. Suneetha, T.S. Rao Rao, M. Srinivasulu, B. Reddy, Overexpression of aldose reductase in human cancer tissues, Med. Sci. Monit. 12 (2006) CR525-529.
119. K.W. Lee, B.C. Ko, Z. Jiang, D. Cao, S.S. Chung, Overexpression of aldose reductase in liver cancers may contribute to drug resistance, Anticancer Drugs 12 (2001) 129-132. (Pubitemid 32207361)
120. I. Kawamura, E. Lacey, N. Yamamoto, F. Sakai, S. Takeshita, M. Inami, F. Nishigaki, Y. Naoe, S. Tsujimoto, T. Manda, K. Shimomura, T. Goto, Ponal-restat, an aldose reductase inhibitor, inhibits cachexia syndrome induced by colon 26 adenocarcinoma in mice, Anticancer Res. 19 (1999) 4105-4111.